Across TCGA pan-cancer cohorts, NUP210P1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NUP210P1 data layer compared with 5 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher NUP210P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NUP210P1 expression acts as an unfavorable survival marker.

LUAD and SARC are the cancer types where NUP210P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.240	0.685	.003	12	view →
SARC	OS	Median	All	0.224	0.826	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NUP210P1 tumor-vs-normal RNA expression · all NUP210P1 data types